4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-020165
EVP, North America Commercial sold 470 shares at $7.16 ($3,367)
- EVP, North America Commercial acquired 1,179 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Grady Brendan P. · EVP, North America Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-17 | Exercise or conversion : show line 1 in the form | +1,179 | 15,338.49 | D | ||
| 2020-03-17 | Sale : show line 2 in the form | −470 | $7.16 | $3,367 | 14,868.49 | D |
| Open-market sales · 470 sh · avg $7.16 · $3,367 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-17 | Exercise or conversion : show line 3 in the form Restricted Share Units | −1,179 | 0 | D |
Loading xslF345X03/doc4.xml…